P/B
3,7
Mesa Laboratories
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
$690M
Market Cap • 10/19/2026
1982
(44 years)
Founded
1984
(42 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
2,8
P/EBITDA
15,2
P/OCF
12,4
P/FCF
13
P/E
146,8
BVPS
33,7
EPS
0,9
Market Cap
Market Cap
690M
EV
802,2M
EV/Revenue
3,2
EV/EBITDA
17,7
EV/EBIT
35,7
Payout
Dividend Per Share
0,6
Dividend Yield
0,5%
Buyback Yield
0%
Total Yield
0,5%
Dividend Yield 5Y
0,6%
Payout
73,6%
Retained Earnings
-183,8M
Profitability
Gross Margin
64,2%
EBITDA Margin
18,2%
EBIT Margin
9%
Net Margin
1,9%
D&A/EBITDA
0%
R&D/Revenue
8%
Capex/Revenue
1,1%
Capex/D&A
12,2%
Capex/OCF
5%
SBC/OCF
29,4%
% PPE
7,2%
% Goodwill
44,4%
ROE
2,7%
ROIC
3%
Growth
CAGR Revenue 5Y
12,4%
CAGR Op. Income 5Y
13,5%
CAGR Net Income 5Y
3,4%
CAGR EPS 5Y
2,6%
CAGR OCF 5Y
4,6%
Leverage
N.D./EBITDA
2,5
Debt/Equity
0%
Current Ratio
1,8
Quick Ratio
1,1
Interest Coverage
207%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!